Literature DB >> 25652566

Detecting clinically meaningful biomarkers with repeated measurements: An illustration with electronic health records.

Benjamin A Goldstein1, Themistocles Assimes2, Wolfgang C Winkelmayer3, Trevor Hastie4.   

Abstract

Data sources with repeated measurements are an appealing resource to understand the relationship between changes in biological markers and risk of a clinical event. While longitudinal data present opportunities to observe changing risk over time, these analyses can be complicated if the measurement of clinical metrics is sparse and/or irregular, making typical statistical methods unsuitable. In this article, we use electronic health record (EHR) data as an example to present an analytic procedure to both create an analytic sample and analyze the data to detect clinically meaningful markers of acute myocardial infarction (MI). Using an EHR from a large national dialysis organization we abstracted the records of 64,318 individuals and identified 4769 people that had an MI during the study period. We describe a nested case-control design to sample appropriate controls and an analytic approach using regression splines. Fitting a mixed-model with truncated power splines we perform a series of goodness-of-fit tests to determine whether any of 11 regularly collected laboratory markers are useful clinical predictors. We test the clinical utility of each marker using an independent test set. The results suggest that EHR data can be easily used to detect markers of clinically acute events. Special software or analytic tools are not needed, even with irregular EHR data.
© 2015, The International Biometric Society.

Entities:  

Keywords:  Biological markers; Dialysis; Longitudinal data; Myocardial infarction; Risk prediction; Splines

Mesh:

Substances:

Year:  2015        PMID: 25652566      PMCID: PMC4479980          DOI: 10.1111/biom.12283

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  20 in total

1.  Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham Offspring Study.

Authors:  Luc Djoussé; Kenneth J Rothman; L Adrienne Cupples; Daniel Levy; R Curtis Ellison
Journal:  Circulation       Date:  2002-12-03       Impact factor: 29.690

2.  Selection of controls in case-control studies. III. Design options.

Authors:  S Wacholder; D T Silverman; J K McLaughlin; J S Mandel
Journal:  Am J Epidemiol       Date:  1992-05-01       Impact factor: 4.897

3.  Prediction modeling using EHR data: challenges, strategies, and a comparison of machine learning approaches.

Authors:  Jionglin Wu; Jason Roy; Walter F Stewart
Journal:  Med Care       Date:  2010-06       Impact factor: 2.983

Review 4.  Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group.

Authors:  Kim A Eagle; Geoffrey S Ginsburg; Kiran Musunuru; William C Aird; Robert S Balaban; Susan K Bennett; Roger S Blumenthal; Shaun R Coughlin; Karina W Davidson; Edward D Frohlich; Philip Greenland; Gail P Jarvik; Peter Libby; Carl J Pepine; Jeremy N Ruskin; Arthur E Stillman; Jennifer E Van Eyk; H Eser Tolunay; Cheryl L McDonald; Sidney C Smith
Journal:  Circulation       Date:  2010-03-30       Impact factor: 29.690

5.  Evaluating prognostic accuracy of biomarkers in nested case-control studies.

Authors:  Tianxi Cai; Yingye Zheng
Journal:  Biostatistics       Date:  2011-08-19       Impact factor: 5.899

6.  The leukocyte count as a predictor of myocardial infarction.

Authors:  G D Friedman; A L Klatsky; A B Siegelaub
Journal:  N Engl J Med       Date:  1974-06-06       Impact factor: 91.245

7.  Positive predictive value of the diagnosis of acute myocardial infarction in an administrative database.

Authors:  L A Petersen; S Wright; S L Normand; J Daley
Journal:  J Gen Intern Med       Date:  1999-09       Impact factor: 5.128

Review 8.  The white blood cell count and risk for coronary heart disease.

Authors:  K Ensrud; R H Grimm
Journal:  Am Heart J       Date:  1992-07       Impact factor: 4.749

9.  Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes.

Authors:  Jean-Pierre Bassand; Rizwan Afzal; John Eikelboom; Lars Wallentin; Ron Peters; Andrzej Budaj; Keith A A Fox; Campbell D Joyner; Susan Chrolavicius; Christopher B Granger; Shamir Mehta; Salim Yusuf
Journal:  Eur Heart J       Date:  2009-10-12       Impact factor: 29.983

Review 10.  Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium.

Authors:  Meinrad Gawaz
Journal:  Cardiovasc Res       Date:  2004-02-15       Impact factor: 10.787

View more
  5 in total

1.  Classifying individuals based on a densely captured sequence of vital signs: An example using repeated blood pressure measurements during hemodialysis treatment.

Authors:  Benjamin A Goldstein; Tara I Chang; Wolfgang C Winkelmayer
Journal:  J Biomed Inform       Date:  2015-08-13       Impact factor: 6.317

2.  Unanticipated Respiratory Compromise and Unplanned Intubations on General Medical and Surgical Floors.

Authors:  Armando D Bedoya; Nrupen A Bhavsar; Bhargav Adagarla; Courtney B Page; Benjamin A Goldstein; Neil R MacIntyre
Journal:  Respir Care       Date:  2020-03-10       Impact factor: 2.339

3.  Linking clinotypes to phenotypes and genotypes from laboratory test results in comprehensive physical exams.

Authors:  Sisi Zeng; Ni Cao; Thanh Nguyen; Tongbin Zhang; Geoffrey Fox; Chuandi Pan; Jake Y Chen
Journal:  BMC Med Inform Decis Mak       Date:  2021-02-24       Impact factor: 3.298

4.  Trajectories of metabolic risk factors and biochemical markers prior to the onset of type 2 diabetes: the population-based longitudinal Doetinchem study.

Authors:  G Hulsegge; A M W Spijkerman; Y T van der Schouw; S J L Bakker; R T Gansevoort; H A Smit; W M M Verschuren
Journal:  Nutr Diabetes       Date:  2017-05-08       Impact factor: 5.097

5.  Trajectories of Metabolic Risk Factors and Biochemical Markers prior to the Onset of Cardiovascular Disease - The Doetinchem Cohort Study.

Authors:  Gerben Hulsegge; Annemieke M W Spijkerman; Yvonne T van der Schouw; Stephan J L Bakker; Ron T Gansevoort; Henriette A Smit; W M Monique Verschuren
Journal:  PLoS One       Date:  2016-05-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.